212 related articles for article (PubMed ID: 11361633)
1. Combination study of Invirase and Norvir starting.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
[No Abstract] [Full Text] [Related]
2. Ritonavir and saquinavir combination: 12-week data at ICAAC.
James JS
AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of HIV infections and AIDS with protease inhibitor and two nucleoside analogs].
Jensen-Fangel S; Larsen L; Thomsen HF; Nielsen LP; Black FT; Obel N
Ugeskr Laeger; 1999 Mar; 161(12):1751-4. PubMed ID: 10210974
[TBL] [Abstract][Full Text] [Related]
4. Saquinavir plus ritonavir reduce viral load by 99.9 percent.
Vazquez E
Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983
[TBL] [Abstract][Full Text] [Related]
5. [New formulation--fewer tablets--optimal effect].
Krankenpfl J; 2005; 43(7-10):249. PubMed ID: 16515318
[No Abstract] [Full Text] [Related]
6. Combination suppresses HIV RNA within the central nervous system.
AIDS Patient Care STDS; 1998 Jan; 12(1):65. PubMed ID: 11361893
[No Abstract] [Full Text] [Related]
7. [Ritonavir/Saqinavir: dual protease inhibitor combination. Salvage therapy].
MMW Fortschr Med; 2000; 142(3 Suppl):41. PubMed ID: 11012293
[No Abstract] [Full Text] [Related]
8. Searching for the right dose of ritonavir-saquinavir.
TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
[No Abstract] [Full Text] [Related]
9. Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
Nieuwkerk P; Gisolf E; Sprangers M; Danner S;
Antivir Ther; 2001 Jun; 6(2):97-103. PubMed ID: 11491422
[TBL] [Abstract][Full Text] [Related]
10. Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
Michelet C; Ruffault A; Sébille V; Arvieux C; Jaccard P; Raffi F; Bazin C; Chapplain JM; Chauvin JP; Dohin E; Cartier F; Bellissant E
Antimicrob Agents Chemother; 2001 Dec; 45(12):3393-402. PubMed ID: 11709314
[TBL] [Abstract][Full Text] [Related]
11. [HIV: to administer protease inhibitors early].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
[No Abstract] [Full Text] [Related]
12. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
[No Abstract] [Full Text] [Related]
13. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
[TBL] [Abstract][Full Text] [Related]
14. [Improving the pharmacokinetics of protease inhibitors in a more innovative manner. HIV drugs administered in a more clever way].
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():18-21. PubMed ID: 11373769
[No Abstract] [Full Text] [Related]
15. Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.
van der Lugt J; Gorowara M; Avihingsanon A; Burger D; Ananworanich J; Sringam K; Kerr S; Wit F; Lange J; Ruxrungtham K
AIDS; 2009 Jun; 23(9):1176-9. PubMed ID: 19451794
[TBL] [Abstract][Full Text] [Related]
16. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
[No Abstract] [Full Text] [Related]
17. Acute hepatitis in a patient treated with saquinavir and ritonavir: absence of cross-toxicity with indinavir.
Vandercam B; Moreau M; Horsmans C; Gala JL
Infection; 1998; 26(5):313. PubMed ID: 9795794
[No Abstract] [Full Text] [Related]
18. A patient's guide to protease inhibitors.
Elperin A; Sax P
AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
[TBL] [Abstract][Full Text] [Related]
19. ["Double boosting" passes the test. LPV/r plus SQV in complicated salvage situation].
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():85. PubMed ID: 15011607
[No Abstract] [Full Text] [Related]
20. Boosted saquinavir approved.
AIDS Patient Care STDS; 2004 Mar; 18(3):183. PubMed ID: 15112642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
